• FirefoxUpgrade to the new Firefox »
  •  Dow Up 2.43% Nasdaq Up 2.24%

    More On LRUSF

    Quotes

    Charts

    News & Info

    Company

    • Profile
    • Key Statistics
    • SEC Filings
    • Competitors
    • Industry
    • Components

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Lorus Therapeutics Inc. (LRUSF)

    -Other OTC
    0.42 Aug 27, 1:00PM EDT
    |Pre-Market : NaN
    Add to Portfolio
    Prev Close:0.42
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:1.82
    Beta:-0.11
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:0.17 - 0.93
    Volume:0
    Avg Vol (3m):9,409
    Market Cap:N/A
    P/E (ttm):N/A
    EPS (ttm):-0.15
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for LRUSF

    Comparison

    Symbol% ChgMkt Cap
    LRUSF 0.00%N/A
    BMY100.84B
    ISIS7.04B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Lorus Therapeutics Inc., a biopharmaceutical company, is engaged in the discovery, research, and development of novel anticancer therapies in Canada. The company’s pipeline of cancer drug candidates includes small molecule therapies and immun... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback